Navigation Links
AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis

Top Global Pharmaceutical Company Integrates Their Clinical Data System (CDS) and East(R) for Improved Clinical Data Handling and Trial Analysis

CAMBRIDGE, Mass., Feb. 13 /PRNewswire/ -- Cytel Inc. today announced that AstraZeneca International has expanded their deployment of Cytel's East(R) software, the most widely-used clinical trial design, simulation and monitoring system available. AstraZeneca's increased use of East(R) also features automated data transfer between their CDS and East's trial monitoring component. By eliminating manual data entry, AstraZeneca achieved the multiple benefits of greater clinical trial analysis efficiency and increased security of vital study data.

Cytel Vice President of Business Development, Steve Herbert, recalled the initial request: "AstraZeneca came to Cytel looking to improve data entry into East(R) from their own Clinical Data System (CDS). Our software engineers worked closely with their AstraZeneca's counterparts to help achieve far more efficient data handling within their CDS path and ensure compliance with Clinical Data Interchange Standards Consortium (CDISC) guidelines."

Maria Johansson, Business Tools Manager at AstraZeneca praised Cytel's response saying, "Cytel's customized version of East(R) for AstraZeneca is now fully integrated with our clinical data system eliminating any manual data handling and better facilitating the data analysis process. This new automation also helps us maintain the integrity of the interim data, reducing the risk of unintentional un-blinding."

Of the experience, Mrs. Johansson remarked, "The cooperation between AstraZeneca and Cytel has been very good. We're very pleased with the outcome."

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.

About Cytel

Cytel Inc. is a leading provider of clinical trial design services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. Cytel's East(R) system is used at hundreds of commercial sites, throughout academia and by regulators to design, simulate and monitor adaptive and group sequential clinical trials. Cytel provides trial sponsors with innovative tools, training and consultation to increase the return on investment in clinical development.

SOURCE Cytel Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
2. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
3. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
4. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
5. Melior Enters Research Collaboration with AstraZeneca
6. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
7. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
8. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
9. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
10. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
11. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, a ... Emily Leproust, Ph.D., Twist Bioscience chief executive officer, ... Conference on December 1, 2015 at 3:10 p.m. ... York City. --> ... . Twist Bioscience is on Twitter. Sign up ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
(Date:11/24/2015)... 24, 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: ... Mr. Pierre Laurin , President and Chief Executive Officer ... upcoming Piper Jaffray 27 th Annual Healthcare Conference to ... 1-2, 2015. st , at 8.50am (ET) ... throughout the day. The presentation will be available live via ...
(Date:11/24/2015)... HemoShear Therapeutics, LLC, a privately held ... disorders, announced today the appointment of H. ... (BOD). Mr. Watkins is the former president and ... and also served as the chairman of the ... Chairman and CEO of HemoShear Therapeutics. "The combination ...
Breaking Biology Technology:
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):